Scarica l'app Stockscreener
216.10
2.02%
4.27
Pre-mercato:
217.15
1.05
+0.49%
Precedente Chiudi:
$211.83
Aprire:
$212.67
Volume 24 ore:
1.11M
Relative Volume:
0.94
Capitalizzazione di mercato:
$30.13B
Reddito:
$2.12B
Utile/perdita netta:
$-309.19M
Rapporto P/E:
-94.61
EPS:
-2.2841
Flusso di cassa netto:
$93.57M
1 W Prestazione:
-0.12%
1M Prestazione:
-10.48%
6M Prestazione:
+30.41%
1 anno Prestazione:
+34.59%
Intervallo 1D:
$211.20
$216.64
Intervallo di 1 settimana:
$207.01
$218.25
Portata 52W:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
216.10 | 29.54B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
520.12 | 192.99B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.36 | 148.11B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
660.71 | 52.49B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.97 | 35.28B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
322.83 | 31.33B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | Citigroup | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Assessing Natera (NTRA) Valuation After Positive SINERGY Trial Results In Head And Neck Cancer - simplywall.st
A Preview Of Natera's Earnings - Benzinga
Natera says Phase 2 SINERGY trial met primary endpoint - TipRanks
Natera Earnings: What To Look For From NTRA - Finviz
Natera (NTRA) Reports Success in SINERGY Trial for Head and Neck Cancer - GuruFocus
Chemo cut by two-thirds with ctDNA-guided care in head and neck cancer study - Stock Titan
Is Natera (NTRA) Fairly Priced After Recent Share Price Pullback? - Yahoo Finance
How Surging Signatera Oncology Volumes At Natera (NTRA) Have Changed Its Investment Story - simplywall.st
Justices Want Natera's Take On CareDx's False Ad Petition - Law360
Natera, Inc. (NTRA) Stock Analysis: High Growth Potential With 21.25% Upside - DirectorsTalk Interviews
Aug Highlights: Is Natera Inc stock forming a triangle patternJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - baoquankhu1.vn
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks - The Motley Fool
Vanguard Group Inc. Sells 287,620 Shares of Natera, Inc. $NTRA - MarketBeat
How does Natera Inc. compare to its peers2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - mfd.ru
Cibc World Market Inc. Sells 6,191 Shares of Natera, Inc. $NTRA - MarketBeat
Will Natera Inc. stock reach all time highs in 2025New Guidance & Daily Technical Stock Forecast Reports - mfd.ru
CtDNA Detection Market Set to Witness Massive Growth by 2033: Key Players • Roche • Biocept • Natera • Illumina - openPR.com
Natera targets ex-employee over mass file download before rival move - Life Sciences Intellectual Property Review
Natera (NTRA) to Release Earnings on Thursday - MarketBeat
Assessing Natera (NTRA) Valuation After Launch Of EDEN Preeclampsia Risk Study - simplywall.st
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
Analysts Offer Insights on Healthcare Companies: American Well (AMWL), Centene (CNC) and Natera (NTRA) - The Globe and Mail
Natera, Inc. $NTRA Shares Sold by Eagle Health Investments LP - MarketBeat
Readystate Asset Management LP Invests $12.74 Million in Natera, Inc. $NTRA - MarketBeat
Piper Sandler reiterates Natera stock rating on Japan expansion By Investing.com - Investing.com South Africa
CareDx gets $96M jury verdict overturned in Natera patent dispute - MSN
Piper Sandler reiterates Natera stock rating on Japan expansion - Investing.com
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026 - Yahoo Finance
Zweig DiMenna Associates LLC Buys 8,400 Shares of Natera, Inc. $NTRA - MarketBeat
JPMorgan Chase & Co. Buys 1,003,129 Shares of Natera, Inc. $NTRA - MarketBeat
Natera's Signatera test to be covered under Medicare - MSN
Natera, Inc. (NTRA) Stock Analysis: Unpacking the 24.72% Potential Upside in the Diagnostics Powerhouse - DirectorsTalk Interviews
Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN
How (NTRA) Movements Inform Risk Allocation Models - Stock Traders Daily
CareDx Seeks High Court Review Of $45M False Ad Case - Law360
Prenatal Testing Co. Missed Fatal Condition, Couple Say - Law360
MSN Money - MSN
Krilogy Financial LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
Envestnet Asset Management Inc. Purchases 17,254 Shares of Natera, Inc. $NTRA - MarketBeat
How Natera Inc. stock trades before earnings2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
Natera Inc (NTRA) Trading 3.93% Higher on Feb 9 - GuruFocus
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? - 富途牛牛
Earnings Miss: What are analysts price targets for Natera Inc2025 Market Overview & Pattern Based Trade Signal System - baoquankhu1.vn
Natera, Inc. $NTRA Shares Sold by Savant Capital LLC - MarketBeat
Is Natera (NTRA) Quietly Redefining Its Moat With Multi-Front Cell-Free DNA Expansion? - simplywall.st
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes - Yahoo Finance
AGF Management Ltd. Sells 6,300 Shares of Natera, Inc. $NTRA - MarketBeat
This brand-new Peninsula building sat vacant for a year. Now it's landed two big tenants - The Business Journals
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Natera Inc Azioni (NTRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Feb 03 '26 |
Sale |
230.77 |
1,639 |
378,229 |
137,847 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Feb 02 '26 |
Sale |
230.72 |
85,299 |
19,680,040 |
127,881 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Feb 03 '26 |
Sale |
230.77 |
4,725 |
1,090,379 |
123,156 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Feb 03 '26 |
Sale |
227.83 |
6,939 |
1,580,926 |
52,120 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Feb 03 '26 |
Sale |
231.02 |
3,594 |
830,279 |
178,081 |
| Sheena Jonathan | CO-FOUNDER |
Feb 03 '26 |
Sale |
230.77 |
435 |
100,384 |
263,161 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Feb 03 '26 |
Sale |
230.77 |
1,334 |
307,845 |
223,813 |
5.39%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):